Last edition
News about "weight management"
Roche Reports Positive Phase 2 Results for Enicepatide
Roche has announced positive phase 2 results for dual GLP-1/GIP receptor agonist enicepatide in people living with Type 2 Diabetes and overweight or obesity.
Weight Management | 23/09/2026 | By News Bureau | 105
MannKind and Rose Pharma Enter Global Collaboration to Develop Inhaled GLP-1 for Weight Management
MannKind and Rose Pharma have entered a worldwide collaboration to develop ROSE-010 Technosphere, an investigational rapid-acting inhaled GLP-1 therapy for weight management.
Weight Management | 10/09/2026 | By News Bureau | 109
Wegovy Pill Prescriptions Surpass 3 Million as Novo Nordisk Presents New ADA 2026 Data
Novo Nordisk announced that Wegovy pill prescriptions have surpassed 3 million since launch, marking one of the largest US pharmaceutical launches by volume. Most prescriptions are from people new to GLP-1 therapy, expanding access to obesity treatment, while new clinical analyses are being presented at ADA 2026.
Weight Management | 10/06/2026 | By News Bureau | 855
Novo Nordisk Launches Wegovy Weight-Loss Pill in UAE, First Market Outside the US
UAE becomes first country outside the United States to offer the oral semaglutide treatment for obesity, marking a key step in Novo Nordisk’s global expansion plans.
Weight Management | 04/06/2026 | By News Bureau | 130
UK MHRA Approves Single-Dose 7.2mg Wegovy Injection for Obesity Treatment
The UK Medicines and Healthcare products Regulatory Agency has approved a single-dose 7.2mg Wegovy pen, simplifying weekly treatment for adults with obesity and a BMI of 30 or higher.
Weight Management | 15/04/2026 | By News Bureau | 239
Biohaven Completes Enrollment in Phase II Trial of Taldefgrobep for Obesity
Biohaven finishes enrollment in Phase II study of taldefgrobep, a novel therapy targeting fat loss and muscle gain, with topline data expected in the second half of 2026.
Weight Management | 21/03/2026 | By News Bureau | 430
Biocon Launches its Glucagon-like Peptide-1 (GLP -1), Liraglutide in Netherlands
Biocon has launched its GLP-1 drug–device combination, Liraglutide, in the Netherlands, where it will be marketed under the brand names Diavorin for diabetes and Vobexoryn for chronic weight management.
Weight Management | 15/12/2025 | By News Bureau | 338
Eli Lilly Reports Positive Phase 3 Topline Results for Oral GLP-1 Orforglipron in Type 2 Diabetes
Eli Lilly and Company has announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials evaluating orforglipron for the treatment of type 2 diabetes.
Weight Management | 16/10/2025 | By Dineshwori | 472
Novo Nordisk presented new findings from its Wegovy and Cagrilintide trials in obesity management at the ongoing European Association for the Study of Diabetes (EASD) 2025 congress in Vienna, Austria.
Weight Management | 17/09/2025 | By Dineshwori | 749
Cipla to Enter Weight Management Segment, Expands Focus on Oncology and CNS Therapies
Cipla is set to enter India’s growing weight management market as part of its broader strategy to expand across emerging therapeutic segments.
Weight Management | 14/07/2025 | By Dineshwori | 290
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy